Patents Assigned to Illumina, Inc.
  • Publication number: 20230152227
    Abstract: There is set forth herein a light energy exciter that can include one or more light sources. A light energy exciter can emit excitation light directed toward a detector surface that can support biological or chemical samples.
    Type: Application
    Filed: January 19, 2023
    Publication date: May 18, 2023
    Applicant: Illumina, Inc.
    Inventors: Rui JIANG, Joseph PINTO
  • Patent number: 11649481
    Abstract: Embodiments of the methods and compositions provided herein relate to the selective cleavage of target nucleic acids. Some embodiments include recombinase-mediated selective cleavage of target nucleic acids with single-stranded nucleic acid probes and a recombinase. Some embodiments also include the enrichment of non-target nucleic acids in a sample by selective cleavage of target nucleic acids in the sample, and removal of the cleaved target nucleic acids from the sample.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: May 16, 2023
    Assignee: Illumina, Inc.
    Inventor: Clifford Lee Wang
  • Patent number: 11649498
    Abstract: Implementations of a method for seeding sequence libraries on a surface of a sequencing flow cell that allow for spatial segregation of the libraries on the surface are provided. The spatial segregation can be used to index sequence reads from individual sequencing libraries to increase efficiency of subsequent data analysis. In some examples, hydrogel beads containing encapsulated sequencing libraries are captured on a sequencing flow cell and degraded in the presence of a liquid diffusion barrier to allow for the spatial segregation and seeding of the sequencing libraries on the surface of the flow cell. Additionally, examples of systems, methods and compositions are provided relating to flow cell devices configured for nucleic acid library preparation and single cell sequencing. Some examples include flow cell devices having a hydrogel with genetic material disposed therein, and which is retained within the hydrogel during nucleic acid processing.
    Type: Grant
    Filed: April 13, 2022
    Date of Patent: May 16, 2023
    Assignee: ILLUMINA, INC.
    Inventors: Tarun Kumar Khurana, Yir-Shyuan Wu, Xi-Jun Chen, Filiz Gorpe-Yasar, Yan-You Lin, Victoria Popic, Erich B. Jaeger, Mostafa Ronaghi
  • Patent number: 11650156
    Abstract: Techniques are described for reducing the number of angles needed in structured illumination imaging of biological samples through the use of patterned flowcells, where nanowells of the patterned flowcells are arranged in, e.g., a square array, or an asymmetrical array. Accordingly, the number of images needed to resolve details of the biological samples is reduced. Techniques are also described for combining structured illumination imaging with line scanning using the patterned flowcells.
    Type: Grant
    Filed: August 3, 2021
    Date of Patent: May 16, 2023
    Assignees: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED
    Inventors: Gary Mark Skinner, Geraint Wyn Evans, Stanley S. Hong
  • Patent number: 11647617
    Abstract: Enclosures and corresponding magnetic joints. An apparatus includes an enclosure. The enclosure includes a magnetic panel joint formed by: a first panel carrying a magnet and comprising a first pocket; a second panel including a second pocket; and a ferromagnetic shield coupled within the second pocket and couplable within the first pocket via the magnet.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: May 9, 2023
    Assignee: ILLUMINA, INC.
    Inventor: Erik Allegoren
  • Patent number: 11643684
    Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: May 9, 2023
    Assignee: Illumina, Inc.
    Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
  • Publication number: 20230135486
    Abstract: The present invention includes methods and materials for use in the detection preeclampsia and/or determining an increased risk for preeclampsia in a pregnant female, the method including identifying in a biosample obtained from the pregnant women a plurality of circulating RNA (C-RNA) molecules.
    Type: Application
    Filed: December 29, 2022
    Publication date: May 4, 2023
    Applicant: ILLUMINA, INC.
    Inventors: Sarah E. Shultzaberger, Fiona Kaper, Sarah Kinnings, Suzanne Rohrback, Carlo Randise-Hinchliff
  • Publication number: 20230125640
    Abstract: Light detection devices and related methods are provided. The devices may comprise a reaction structure for containing a reaction solution with a relatively high or low pH and a plurality of reaction sites that generate light emissions. The devices may comprise a device base comprising a plurality of light sensors, device circuitry coupled to the light sensors, and a plurality of light guides that block excitation light but permit the light emissions to pass to a light sensor. The device base may also include a shield layer extending about each light guide between each light guide and the device circuitry, and a protection layer that is chemically inert with respect to the reaction solution extending about each light guide between each light guide and the shield layer. The protection layer prevents reaction solution that passes through the reaction structure and the light guide from interacting with the device circuitry.
    Type: Application
    Filed: December 22, 2022
    Publication date: April 27, 2023
    Applicant: Illumina, Inc.
    Inventors: Xiuyu CAI, Joseph Francis PINTO, Thomas A. BAKER, Tracy Helen FUNG
  • Publication number: 20230126668
    Abstract: There is set forth herein, in one example, a device comprising: a detector surface; an array of sensing photodiodes formed in a semiconductor formation, wherein the semiconductor formation receives light from the detector surface; and a light separating structure intermediate the detector surface and a sensing photodiode of the array of sensing photodiodes.
    Type: Application
    Filed: October 21, 2022
    Publication date: April 27, 2023
    Applicant: ILLUMINA, INC.
    Inventors: Arvin EMADI, Ravi Billa, Mohsen Rezaei, Craig Hetherington
  • Patent number: 11634746
    Abstract: A portable detector is disclosed for detecting certain analytes of interest, such as genetic material (e.g., nucleic acids). The detector includes a reading component for the detection of the analytes, and control circuitry for controlling operation of the reading component. Processing circuitry may be included to perform both primary analysis of acquired data, and where desired, secondary analysis. Where desired, some or all of the computationally intensive tasks may be off-loaded to enhance the portability and speed of the device. The device may incorporate various types of interface, technologies for reading and analysis, positioning system interfaces, and so forth. A number of exemplary use cases and methods are also disclosed.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: April 25, 2023
    Assignee: Illumina, Inc.
    Inventors: Robert C. Kain, Min-Jui Richard Shen, John A. Moon, Helmy A. Eltoukhy
  • Patent number: 11634697
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain high fidelity under reduced incorporation times, as well as methods and kits using the same.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: April 25, 2023
    Assignees: Illumina, Inc., Illumina Cambridge Limited, Illumina Singapore Pte. Ltd.
    Inventors: Kay Klausing, Hamed Tabatabaei Ghomi, Misha Golynskiy, Saurabh Nirantar, Seth McDonald, Sergio Peisajovich
  • Patent number: 11634707
    Abstract: Embodiments of the present invention relate to analyzing components of a cell. In some embodiments, the present invention relate to analyzing components of a single cell. In some embodiments, the methods and compositions relate to sequencing nucleic acids. In some embodiments, the methods and compositions relate to identifying and/or quantitating nucleic acid, proteins, organelles, and/or cellular metabolites.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: April 25, 2023
    Assignee: ILLUMINA, INC.
    Inventors: Kevin L Gunderson, Frank J Steemers, Jeffrey S Fisher, Roberto Rigatti
  • Patent number: 11629378
    Abstract: Disclosed are methods for determining at least one sequence of interest of a fetus of a pregnant mother. In various embodiments, the method can determine one or more sequences of interest in a test sample that comprises a mixture of maternal cellular DNA and mother-and-fetus cfDNA. In some embodiments, methods are provided for determining whether the fetus has a genetic disease. In some embodiments, methods are provided for determining whether the fetus is homozygous in a disease causing allele when the mother is heterozygous of the same allele. In some embodiments, methods are provided for determining whether the fetus has a copy number variation (CNV) or a non-CNV genetic sequence anomaly.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: April 18, 2023
    Assignee: Illumina, Inc.
    Inventors: Anupama Srinivasan, Darya I. Chudova, Richard P. Rava
  • Patent number: 11629373
    Abstract: Under one aspect, a composition includes a substrate; a first polynucleotide coupled to the substrate; a second polynucleotide hybridized to the first polynucleotide; and a catalyst coupled to a first nucleotide of the second polynucleotide, the catalyst being operable to cause a chemiluminogenic molecule to emit a photon. Under another aspect, a method includes providing a catalyst operable to cause a first chemiluminogenic molecule to emit a photon; providing a substrate; providing a first polynucleotide coupled to the substrate; hybridizing a second polynucleotide to the first polynucleotide; coupling a first quencher to a first nucleotide of the second polynucleotide; and inhibiting, by the first quencher, photon emission by the first chemiluminogenic molecule.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: April 18, 2023
    Assignee: Illumina, Inc.
    Inventors: Boyan Boyanov, Liangliang Qiang, Kevin L. Gunderson, Kay Klausing, Lea Pickering, Cyril Delattre, Tarun Khurana
  • Patent number: 11624084
    Abstract: Presented herein are methods and compositions for enhancing specific enrichment of target sequences in a nucleic acid library. Off-target hybridization probes may be used to reduce binding and/or capture of off-target regions of a nucleic acid library in a targeted sequencing workflow. The off-target hybridization probes may be specific for locations known to generate off-target sequencing reads for a particular set of hybridization probes.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: April 11, 2023
    Assignee: ILLUMINA, INC.
    Inventors: Li Teng, Chia-Ling Hsieh, Charles Lin, Han-Yu Chuang
  • Publication number: 20230108241
    Abstract: The technology disclosed relates to determining pathogenicity of nucleotide variants. In particular, the technology disclosed relates to specifying a particular amino acid at a particular position in a protein as a gap amino acid, and specifying remaining amino acids at remaining positions in the protein as non-gap amino acids, generating a gapped spatial representation of the protein that includes spatial configurations of the non-gap amino acids, and excludes a spatial configuration of the gap amino acid, determining an evolutionary conservation at the particular position of respective amino acids of respective amino acid classes based at least in part on the gapped spatial representation, and based at least in part on the evolutionary conservation of the respective amino acids, determining a pathogenicity of respective nucleotide variants that respectively substitute the particular amino acid with the respective amino acids in alternate representations of the protein.
    Type: Application
    Filed: September 26, 2022
    Publication date: April 6, 2023
    Applicants: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Tobias HAMP, Hong GAO, Kai-How FARH
  • Publication number: 20230108368
    Abstract: The technology disclosed relates to training a pathogenicity predictor.
    Type: Application
    Filed: September 26, 2022
    Publication date: April 6, 2023
    Applicants: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Tobias HAMP, Hong GAO, Kai-How FARH
  • Patent number: 11618808
    Abstract: Some embodiments described herein relate to a substrate with a surface comprising a silane or a silane derivative covalently attached to optionally substituted cycloalkene or optionally substituted heterocycloalkene for direct conjugation with a functionalized molecule of interest, such as a polymer, a hydrogel, an amino acid, a nucleoside, a nucleotide, a peptide, a polynucleotide, or a protein. In some embodiments, the silane or silane derivative contains optionally substituted norbornene or norbornene derivatives. Method for preparing a functionalized surface and the use in DNA sequencing and other diagnostic applications are also disclosed.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: April 4, 2023
    Assignee: Illumina, Inc.
    Inventors: Lorenzo Berti, Andrew A. Brown, Wayne N. George
  • Publication number: 20230094911
    Abstract: Described herein are solid supports and methods for depleting library fragments prepared from unwanted RNA sequences and/or enriching library fragments prepared from desired RNA sequences. These methods may incorporate microfluidics and flowcells for greater ease of use. Libraries enriched or depleted with the present methods may be used for sequencing. Also described are probes and methods for enzymatic depletion of ribosomal RNA from human microbiome samples.
    Type: Application
    Filed: September 30, 2022
    Publication date: March 30, 2023
    Applicant: ILLUMINA, INC.
    Inventors: Robert Scott Kuersten, Jeffrey Koble
  • Publication number: 20230102550
    Abstract: Provided herein are various examples of a method of coupling oligonucleotides to a polymer. The method may include selectively irradiating first inactive moieties in a one or more first region of a polymer with light, while not irradiating second inactive moieties in a one or more second region of the polymer, to generate first active moieties in the one or more first region of the polymer. The method may also include coupling the first active moieties to first oligonucleotides. The method may further include irradiating the second inactive moieties in the one or more second region of the polymer with light to generate second active moieties in the one or more second region of the polymer. The method may also include coupling the second active moieties to second oligonucleotides.
    Type: Application
    Filed: July 29, 2022
    Publication date: March 30, 2023
    Applicants: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED
    Inventors: Weixian XI, Tanmay GHONGE, Sahngki HONG, Alexandra SZEMJONOV